Abstract
Over 160 stem cell–based therapeutic products are undergoing development for the treatment of several diseases, ranging from cardiac and artery diseases to immune and neurodegenerative pathologies, including diabetes, spinal cord injury. Therefore, stem cell therapy plays a key role for developing new cell-based drugs for the future molecular and regenerative medicine. The second meeting organized by Stem Cell Research Italy (SCR Italy) and by the International Society for Cellular Therapy-Europe (ISCT) in Montesilvano/Città S. Angelo (Pescara)–Italy, on June 10th–12th, 2011, focused on the state-of-the-art of stem cell therapy and associated novel findings on stem cell research (
Get full access to this article
View all access options for this article.